From Data to Discovery: The Story of LCTA – A Novel Class of Anticancer Compounds Targeting Thioredoxin Reductase
Cancer remains one of the greatest medical challenges of our time, and the development of new treatment strategies is crucial. At geneXplain, we have pioneered a unique computational methodology – upstream analysis – which has enabled us to identify and develop a new family of anticancer compounds, now patented under…